Warfarin

"Warfarin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.

Descriptor ID	D014859
MeSH Number(s)	D03.383.663.283.446.520.914 D03.633.100.150.446.520.914
Concept/Terms	Warfarin Warfarin 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one Apo-Warfarin Apo-Warfarin Aldocumar Aldocumar Gen-Warfarin Gen-Warfarin Warfant Warfant Coumadin Coumadin Marevan Warfarin Potassium Warfarin Potassium Potassium, Warfarin Warfarin Sodium Warfarin Sodium Sodium, Warfarin Coumadine Coumadine Tedicumar Tedicumar

Below are MeSH descriptors whose meaning is more general than "Warfarin".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Pyrans [D03.383.663]
Benzopyrans [D03.383.663.283]
Coumarins [D03.383.663.283.446]
4-Hydroxycoumarins [D03.383.663.283.446.520]
Warfarin [D03.383.663.283.446.520.914]
Heterocyclic Compounds, Fused-Ring [D03.633]
Heterocyclic Compounds, 2-Ring [D03.633.100]
Benzopyrans [D03.633.100.150]
Coumarins [D03.633.100.150.446]
4-Hydroxycoumarins [D03.633.100.150.446.520]
Warfarin [D03.633.100.150.446.520.914]

Below are MeSH descriptors whose meaning is related to "Warfarin".

Below are MeSH descriptors whose meaning is more specific than "Warfarin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Warfarin" by people in this website by year, and whether "Warfarin" was a major or minor topic of these publications.

Bar chart showing 173 publications over 24 distinct years, with a maximum of 17 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	1	2
2001	1	1	2
2002	3	1	4
2003	2	3	5
2004	4	4	8
2005	1	3	4
2006	3	0	3
2007	5	0	5
2008	4	4	8
2009	3	5	8
2010	6	2	8
2011	6	1	7
2012	10	1	11
2013	13	3	16
2014	9	2	11
2015	10	3	13
2016	9	8	17
2017	6	0	6
2018	8	2	10
2019	4	2	6
2020	2	7	9
2021	1	2	3
2022	1	5	6
2024	1	0	1

Below are the most recent publications written about "Warfarin" by people in Profiles.

Anandalwar SP, O'Meara L, Vesselinov R, Zhang A, Baum JN, Cooper A, Decker C, Schroeppel T, Cai J, Cullinane D, Catalano RD, Bugaev N, LeClair M, Feather C, McBride K, Sams V, Leung PS, Olafson S, Callahan DS, Posluszny J, Moradian S, Estroff J, Hochman B, Coleman N, Goldenberg-Sandau A, Nahmias J, Rosenbaum K, Pasley J, Boll L, Hustad L, Reynolds J, Truitt M, Ghneim M. Warfarin, not direct oral anticoagulants or antiplatelet therapy, is associated with increased bleeding risk in emergency general surgery patients: Implications in this new era of novel anticoagulants: An EAST multicenter study. J Trauma Acute Care Surg. 2024 Aug 01; 97(2):225-232.

View in: PubMed
Nugent S, Karaisz F, Elbadawi M, Touati A, Nikbakht N, Lee JB, Arif H. An unexpected case of non-uremic calciphylaxis in a patient with multiple risk factors. Dermatol Online J. 2022 Dec 15; 28(6).

View in: PubMed
Mar PL, Gopinathannair R, Gengler BE, Chung MK, Perez A, Dukes J, Ezekowitz MD, Lakkireddy D, Lip GYH, Miletello M, Noseworthy PA, Reiffel J, Tisdale JE, Olshansky B. Drug Interactions Affecting Oral Anticoagulant Use. Circ Arrhythm Electrophysiol. 2022 06; 15(6):e007956.

View in: PubMed
Shohat N, Goel R, Ludwick L, Parvizi J. Time to Venous Thromboembolism Events Following Total Hip Arthroplasty: A Comparison Between Aspirin and Warfarin. J Arthroplasty. 2022 06; 37(6):1198-1202.e1.

View in: PubMed
Shohat N, Ludwick L, Sutton R, Chisari E, Parvizi J. Aspirin Administered for Venous Thromboembolism Prophylaxis May Protect Against Stiffness Following Total Knee Arthroplasty. J Arthroplasty. 2022 05; 37(5):953-957.

View in: PubMed
Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, Patel MR, Wallentin L, Alexander JH, Cecilia Bahit M, Benz AP, Bohula EA, Chao TF, Dyal L, Ezekowitz M, A A Fox K, Gencer B, Halperin JL, Hijazi Z, Hohnloser SH, Hua K, Hylek E, Toda Kato E, Kuder J, Lopes RD, Mahaffey KW, Oldgren J, Piccini JP, Ruff CT, Steffel J, Wojdyla D, Granger CB. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex. Circulation. 2022 01 25; 145(4):242-255.

View in: PubMed
Tai WA. Stroke: Primary Prevention. FP Essent. 2022 Jan; 512:11-17.

View in: PubMed
Mamas MA, Batson S, Pollock KG, Grundy S, Matthew A, Chapman C, Manuel JA, Farooqui U, Mitchell SA. Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation. Am J Cardiol. 2022 03 01; 166:58-64.

View in: PubMed
Chaudhry UA, Ezekowitz MD, Gracely EJ, George WT, Wolfe CM, Harper G, Harper GR. Comparison of Low-Dose Direct Acting Anticoagulant and Warfarin in patients Aged =80 years With Atrial Fibrillation. Am J Cardiol. 2021 08 01; 152:69-77.

View in: PubMed
Millenaar D, Schumacher H, Brueckmann M, Eikelboom JW, Ezekowitz M, Slawik J, Ewen S, Ukena C, Wallentin L, Connolly S, Yusuf S, B?hm M. Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial). Am J Cardiol. 2021 06 15; 149:27-35.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement